Woodcock: High Prices Create Problems For Entire Accelerated Approval Program

 
• By Sarah Karlin-Smith
  
price tag
High price tags are leading to opposition to FDA’s accelerated approval program, Woodcock says • Source: Alamy

More from US FDA

More from Agency Leadership